Skip to main content

Discussion around the anti-COVID-19 potential of different cannabis extracts in reducing inflammation

Please join us for a conversation about a study published in 2022 in the journal Cell Death Discovery entitled: “New AKT-dependent mechanisms of anti-COVID-19 action of high-CBD Cannabis sativa extracts”, in which Drs. Olga and Igor Kovalchuk, and Dr. Sitbon discuss the mechanisms of a wide array of cannabis extracts in modulating receptors and inflammation in the context of COVID-19.

mm

Author Yoel H. Sitbon

Yoel is a Medical Writer in the Medical Content division at Csequence. His scientific expertise is in Neuroscience (neural mechanisms behind drug addiction) and Molecular & Cellular Pharmacology (molecular mechanisms behind mutations induced cardiovascular diseases). Yoel has over five years of scientific writing experience as evidenced by 8 peer-reviewed publications in scientific journals. He is an effective oral communicator having presented his PhD thesis work at many biomedical conferences nationally. He also has strong mentorship and leadership experience. Yoel has a B.S in Neuroscience at the University of California, Los Angeles and a Ph.D. in Molecular & Cellular Pharmacology at the University of Miami, Miller School of Medicine.

More posts by Yoel H. Sitbon